Related Experiment Videos
A human gall-bladder signet ring cell carcinoma cell line
Pathology International
|June 1, 1997
Summary
Researchers established a novel human gall-bladder cancer cell line, FU-GBC-2, exhibiting signet ring cell morphology. This new cell line, characterized by specific biomarkers and genetic alterations, offers a valuable tool for studying gall-bladder adenocarcinoma.
Area of Science:
- Oncology
- Cell Biology
- Gastroenterology
Background:
- Limited availability of established gall-bladder cancer cell lines, particularly for signet ring cell carcinoma.
- Previous reports on gall-bladder cell lines are scarce, hindering research in this area.
Purpose of the Study:
- To establish and characterize a new human gall-bladder cancer cell line.
- To provide a valuable research tool for studying gall-bladder adenocarcinoma and signet ring cell carcinoma.
Main Methods:
- Establishment of a cell line (FU-GBC-2) from patient ascitic fluid.
- Morphological analysis using phase contrast and electron microscopy.
- Heterotransplantation into nude mice, immunocytochemistry, cytogenetic analysis, and molecular studies (Southern blot for c-myc).
Main Results:
- The FU-GBC-2 cell line exhibits signet ring cell morphology.
- Successful heterotransplantation and positive staining for CEA, CA19-9, and EMA.
- Demonstrated aneuploidy and amplification of the c-myc oncogene.
Conclusions:
- The FU-GBC-2 cell line is a novel and valuable resource for gall-bladder cancer research.
- This cell line possesses characteristics of signet ring cell carcinoma and gall-bladder adenocarcinoma.
- Further studies using FU-GBC-2 can elucidate the biological and morphological aspects of these cancers.